PTAFR and COVID-19: Detailed in vivo and in vitro studies will be required to better understand the viral-host dynamics with respect to T-PA (PLAT) and PAFR (PTAFR) activation and the subsequent systemic inflammatory responses, in symptomatic and asymptomatic COVID-19 populations.